InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the complete record of transactions filed by SLONIN JONATHAN, Directeur Clinique. Officer active across 1 companies, notably Pacira BioSciences, Inc.. In total, 4 filings have been published. Total volume traded: €21k. The latest transaction was filed on 6 June 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€20,781362 shares@ €57.40490.0020% mcap17.5% of flow
Common Stock
SEC:0001209191-22-035232:0·
€98,0522,000 shares@ €49.02620.0092% mcap82.5% of flow
Common Stock
SEC:0001209191-22-031854:0·
05,000 shares0
Common Stock
SEC:0001209191-21-049940·
05,000 shares0
Common Stock
SEC:0001209191-21-049940:0·
4 of 4 declarations
About SLONIN JONATHAN
Jonathan Slonin serves as Chief Clinical Officer at Pacira BioSciences, Inc. He is responsible for the company's clinical strategy, overseeing research and development initiatives. His expertise is essential for innovation and regulatory compliance.
